Kanaph Therapeutics

Kanaph Therapeutics

Developing next generation therapeutics for oncology and autoimmune diseases.

HQ location
South Korea
Website
kanaphtx.com
Launch date
Employees
11-50 people
Enterprise value
$95—143m
Company register number
6438701092
https://www.linkedin.com/company/kanaph/
    • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor investor

€0.0

round
investor investor investor

€0.0

round
*

$23.8m

Series B
Total Funding000k
GC Pharma
GC Pharma
Kolon Investment
Kolon Investment
Timefolio Asset Management
Timefolio Asset Management
Meritz Securities
Meritz Securities
Aju IB Investment
Aju IB Investment
Wooshin Venture Investment
Wooshin Venture Investment
GC Green Cross Wellbeing
GC Green Cross Wellbeing
Lotte Biologics
Lotte Biologics
Intervest
Intervest
Primer
Primer
Solidus Investment
Solidus Investment
Daily Partners
Daily Partners
NH Venture Investment
NH Venture Investment

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads